Review Article

Cytokine-Mediated Bone Destruction in Rheumatoid Arthritis

Table 2

Effects of biologic therapies on bone.

MiceHuman

TNF- blockersBone-protective in inflammatory arthritis and estrogen deficiencyBone-protective in inflammatory disease
Changes in bone turnover markers in postmenopause (small observational study)
References: [152158]References: [17, 19, 20, 159]

IL-1 blockersBone-protective in inflammatory arthritis and estrogen deficiencyBone-protective in RA (not usually recommended; less effective than other biologic agents)
Changes in bone turnover markers in postmenopause (small observational study)
References: [28, 155, 157]References: [19, 160, 161]

IL-6 blockersBone-protective in inflammatory arthritis
No effects in estrogen deficiency
Bone-protective in RA
References: [155, 156, 162, 163]References: [41, 42, 164, 165]

IL-17 blockersBone-protective in inflammatory arthritis and estrogen deficiencyNo data in bone metabolism
References: [55, 138, 144, 166, 167]

IL-23 blockersBone-protective in inflammatory arthritisNo data
References: [56]